Akero Therapeutics, Inc.

CIK 1744659 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Akero Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 17, 2026SCHEDULE 13G/A0001274173-26-000064
Feb 17, 2026SCHEDULE 13G/A0001493215-26-000022
Feb 13, 2026SCHEDULE 13G/A0001172661-26-000709
Feb 10, 2026SCHEDULE 13G/A0000902219-26-000090
Dec 19, 202515-12G0001140361-25-046189
Dec 9, 202540001193125-25-312115
Dec 9, 202540001193125-25-312131
Dec 9, 202540001193125-25-312116
Dec 9, 2025S-8 POS0001140361-25-044960
Dec 9, 202540001193125-25-312127
Dec 9, 202540001193125-25-312098
Dec 9, 202525-NSE0001354457-25-001233
Dec 9, 2025S-8 POS0001140361-25-044961
Dec 9, 202540001193125-25-312109
Dec 9, 2025S-8 POS0001140361-25-044951
Dec 9, 202540001193125-25-312133
Dec 9, 2025POSASR0001140361-25-044950
Dec 9, 2025S-8 POS0001140361-25-044958
Dec 9, 2025S-8 POS0001140361-25-044963
Dec 9, 202540001193125-25-312111
Dec 9, 202540001193125-25-312122
Dec 9, 20258-K0001140361-25-044946
Dec 9, 2025S-8 POS0001140361-25-044959
Dec 9, 2025S-8 POS0001140361-25-044962
Dec 9, 202540001193125-25-312092